EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.16, sa.11, ss.1519-1524, 2012 (SCI-Expanded)
AIM: The aim of the study was to investigate the effects of rosiglitazone treatment on insulin resistance (IR) and tumor necrosis factor-alpha (TNF-alpha) levels in nondiabetic chronic kidney disease (CKD) patients with IR.